Home→Releases

Releases

Pomerantz LLP Launches Investigation into SELLAS Life Sciences
Releases

Pomerantz LLP Launches Investigation into SELLAS Life Sciences

A 13.15% drop in SELLAS Life Sciences stock has triggered a formal investigation by Pomerantz LLP, as shareholders question the company’s transparency regarding critical clinical trial data for its experimental drug, Galinpepimut-S, following the milestone 80th patient death recorded in August.

Money Talk·Sep 25
ServiceTitan Investors Face Scrutiny Following Sharp Stock Decline
Releases

ServiceTitan Investors Face Scrutiny Following Sharp Stock Decline

Following a 30% drop in share price after a disappointing earnings report, New York-based Pomerantz LLP has launched an investigation into ServiceTitan, Inc. The inquiry examines whether company leadership engaged in securities fraud or unlawful business practices during the transition to their new AI-powered software package, Max.

Money Talk·Sep 25
Lincoln Educational Faces Class Action Suit Following Stock Plunge
Releases

Lincoln Educational Faces Class Action Suit Following Stock Plunge

Investors who suffered losses in Lincoln Educational Services Corp. are facing a November 10, 2026, deadline to seek lead plaintiff status in a newly filed class action lawsuit. The litigation centers on allegations of securities fraud and deceptive business practices tied to the company's recent performance disclosures.

Pomerantz LLP Files Class Action Against Pentwater Capital Over Avis Stock
Releases

Pomerantz LLP Files Class Action Against Pentwater Capital Over Avis Stock

A federal class action lawsuit filed in the Middle District of Florida accuses Pentwater Capital Management and its CEO, Matthew Halbower, of orchestrating a market manipulation scheme that triggered an artificial short squeeze in Avis Budget Group stock, causing massive price volatility and significant losses for retail investors.

Blaize Holdings Faces Class Action Over Alleged Fraudulent Deal
Releases

Blaize Holdings Faces Class Action Over Alleged Fraudulent Deal

A 12% drop in Blaize Holdings stock following a short-seller report has triggered a class action lawsuit, with investors now facing an October 5 deadline to seek lead plaintiff status. The litigation centers on claims that the company inflated its valuation through a partnership with a questionable startup.

Money Talk·Sep 25
Bluerock Acquisition Corp. II Prices $150 Million IPO
Releases

Bluerock Acquisition Corp. II Prices $150 Million IPO

New York-based blank check company Bluerock Acquisition Corp. II priced its initial public offering at $150 million on Tuesday, offering 15 million units at $10 each. The securities are slated to begin trading on the Nasdaq Global Market under the ticker symbol BRRKU starting September 25, 2026.

Money Talk·Sep 25
Investors Face September Deadline in Wise Group Securities Lawsuit
Releases

Investors Face September Deadline in Wise Group Securities Lawsuit

Investors holding Wise Group plc shares face a September 29, 2026, deadline to seek appointment as lead plaintiff in a class action lawsuit. The litigation targets the company over allegations of securities fraud, following reports of money laundering investigations and the rejection of a U.S. banking license application.

Money Talk·Sep 25
Investors Face September 28 Deadline in iTonic Holdings Class Action
Releases

Investors Face September 28 Deadline in iTonic Holdings Class Action

Investors who suffered losses in iTonic Holdings, formerly known as Pheton Holdings, have until September 28, 2026, to seek appointment as lead plaintiff in a pending class action lawsuit. The litigation centers on allegations of a coordinated pump-and-dump scheme that devastated the company's valuation last year.

Investors File Class Action Against AST SpaceMobile Over Capital Concerns
Releases

Investors File Class Action Against AST SpaceMobile Over Capital Concerns

A class action lawsuit filed in the Western District of Texas accuses AST SpaceMobile of misleading investors about the company's financial health and competitive standing. The complaint alleges that leadership overstated the durability of its market position while failing to disclose mounting capital requirements and slow user adoption.

Celsius Holdings Faces Class Action Over Energy Drink Marketing
Releases

Celsius Holdings Faces Class Action Over Energy Drink Marketing

A class action lawsuit filed in the Southern District of Florida accuses Celsius Holdings of misleading investors regarding the health risks and marketing practices of its Alani Nu energy drink line, specifically targeting the potential dangers posed to teenagers and children by the brand's high caffeine content.

Money Talk·Sep 25
Investors Face Deadline in Rackspace Technology Class Action Lawsuit
Releases

Investors Face Deadline in Rackspace Technology Class Action Lawsuit

Investors who incurred losses from Rackspace Technology stock have until September 28, 2026, to petition the court for lead plaintiff status. The class action suit centers on allegations of securities fraud, following a significant downward revision in the company's financial guidance earlier this year that triggered a sharp share price decline.

Alarum Technologies Faces Class Action Lawsuit Following FBI Probe
Releases

Alarum Technologies Faces Class Action Lawsuit Following FBI Probe

A 20.8% plunge in stock price on July 2, 2026, signaled the start of a volatile week for Alarum Technologies investors. Following reports of an FBI-led operation targeting the company's subsidiary, NetNut, for alleged involvement in malicious proxy networks, Pomerantz LLP has launched a class action lawsuit regarding potential securities fraud.

Aardvark Therapeutics Faces Class Action Over IPO Disclosures
Releases

Aardvark Therapeutics Faces Class Action Over IPO Disclosures

Investors have launched a class action lawsuit against Aardvark Therapeutics, alleging the biopharmaceutical firm misled shareholders regarding the safety and commercial viability of its lead drug candidate, ARD-101. The suit claims the company’s initial public offering documents and subsequent statements masked significant risks that later triggered a collapse in share value.

Investors Target Capricor Therapeutics in Securities Class Action
Releases

Investors Target Capricor Therapeutics in Securities Class Action

A federal class action lawsuit now targets Capricor Therapeutics following allegations that the company misled investors regarding the efficacy of its Duchenne muscular dystrophy treatment, deramiocel. The litigation, filed by Pomerantz LLP, addresses a precipitous stock decline triggered by regulatory scrutiny over the company's statistical analysis methods.

Money Talk·Sep 25
TruGolf Faces Securities Fraud Class Action Over Stock Dilution
Releases

TruGolf Faces Securities Fraud Class Action Over Stock Dilution

Investors who purchased TruGolf Holdings stock are being urged to join a class action lawsuit filed by Pomerantz LLP. The litigation alleges that the company misled shareholders regarding its capital structure and the massive, rapid dilution caused by the conversion of Series A preferred stock.

Fractyl Health Faces Class Action Lawsuit Over Clinical Study Disclosures
Releases

Fractyl Health Faces Class Action Lawsuit Over Clinical Study Disclosures

Investors have launched a class action lawsuit against Fractyl Health, Inc. and its top executives, alleging the company misled shareholders regarding the efficacy of its Revita DMR System. The suit claims management obscured operational failures in a critical clinical study, leading to a sharp decline in share value.

Money Talk·Sep 25
Bloom Energy Faces Class Action Lawsuit Over Supply Chain Allegations
Releases

Bloom Energy Faces Class Action Lawsuit Over Supply Chain Allegations

Shareholders of Bloom Energy Corporation have until September 28, 2026, to seek appointment as lead plaintiff in a class action lawsuit. The filing follows allegations that the company misled investors regarding its reliance on Chinese-sourced scandium, a claim that triggered a notable decline in the firm’s stock price.

Investors File Securities Class Action Against AppLovin
Releases

Investors File Securities Class Action Against AppLovin

Pomerantz LLP has initiated a class action lawsuit against AppLovin Corporation in the Northern District of California, alleging that the company misled shareholders regarding the development of its generative AI tools and the efficacy of its advertising models throughout the first half of 2026.

Money Talk·Sep 25
Investors Face Deadline in Park Ha Biological Technology Fraud Lawsuit
Releases

Investors Face Deadline in Park Ha Biological Technology Fraud Lawsuit

Investors who suffered losses in Park Ha Biological Technology Co., Ltd. have until September 28, 2026, to seek appointment as lead plaintiff in a pending class action lawsuit. The litigation targets alleged securities fraud and market manipulation schemes following the company's tumultuous initial public offering.

Pentair Faces Class Action Lawsuit Following July Guidance Cut
Releases

Pentair Faces Class Action Lawsuit Following July Guidance Cut

Investors who suffered losses in Pentair plc are facing a critical deadline as a class action lawsuit moves forward against the company. The litigation follows a sharp decline in share value earlier this year, centered on allegations of securities fraud and misleading business practices regarding pool channel inventory.

Bioinformatics Market Projected to Triple to $64.6 Billion by 2034
Releases

Bioinformatics Market Projected to Triple to $64.6 Billion by 2034

The global bioinformatics market is set for a decade of rapid expansion, with projections indicating a rise from $20.34 billion in 2025 to $64.60 billion by 2034. Driven by a 13.7% compound annual growth rate, the sector is being fundamentally reshaped by the integration of artificial intelligence and next-generation sequencing.

Money Talk·Sep 25
Investors File Class Action Lawsuit Against DICK'S Sporting Goods
Releases

Investors File Class Action Lawsuit Against DICK'S Sporting Goods

A 30% plunge in share price following disappointing second-quarter results has triggered a class action lawsuit against DICK'S Sporting Goods. Investors who acquired securities in the retail giant face a November 3, 2026, deadline to seek appointment as lead plaintiff in the ongoing litigation regarding potential securities fraud.

McCormick Maintains Dividend Streak Into 102nd Year
Releases

McCormick Maintains Dividend Streak Into 102nd Year

Investors holding McCormick & Company common stock will receive a quarterly dividend of $0.48 per share on October 26, 2026. This payout marks a milestone for the Hunt Valley-based flavor giant, extending a record of consecutive annual dividend distributions that now spans over a century of corporate history.

Beta Bionics Faces Securities Class Action Over FDA Reporting Failures
Releases

Beta Bionics Faces Securities Class Action Over FDA Reporting Failures

Investors are lining up to join a class action lawsuit against Beta Bionics, Inc. following revelations that the medical device maker downplayed severe regulatory warnings regarding its iLet Bionic Pancreas system. The firm Pomerantz LLP is representing shareholders who suffered losses after the company’s stock plummeted throughout early 2026.

Money Talk·Sep 25
Forge Commits $30 Million to webAI for Enterprise Intelligence
Releases

Forge Commits $30 Million to webAI for Enterprise Intelligence

The enterprise artificial intelligence market is pivoting away from generic models toward private, specialized systems as Forge AI Deployment commits $30 million to partner with webAI. The agreement aims to move beyond experimental AI demos, focusing on integrating sovereign intelligence directly into proprietary corporate workflows and controlled hardware infrastructure.